Nanotechnology institute formed in St. Louis
Funding from the Missouri Life Sciences Research Fund, part of the 1998 state tobacco settlement, will establish the St. Louis Institute of Nanomedicine Working Group, a collaborative regional effort to apply advances in nanotechnology to the treatment of human diseases.
Bacteria in urinary tract infections caught stealing iron
Bacteria that cause urinary tract infections make more tools for stealing from their host than friendly versions of the same bacteria found in the gut.
TV crime drama compound highlights immune cells’ misdeeds
Detectives on television shows often spray crime scenes with a compound called luminol to make blood glow. Researchers at the School of Medicine have applied the same compound to much smaller crime scenes: sites where the immune system attacks the body’s own tissues.
Ticking of body’s 24-hour clock turns gears of metabolism and aging
All animals, including humans, have an internal 24-hour clock or circadian rhythm that creates a daily oscillation of body temperature, brain activity, hormone production and metabolism. Studying mice, researchers at the School of Medicine and Northwestern University found how the biological circadian clock mechanism communicates with processes that govern aging and metabolism.
StoryCorps to capture parents’ stories at Siteman Cancer Center
Nationally recognized StoryCorps will visit the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine April 17-21 as part of a collaborative project to better understand how parents with cancer discuss the diagnosis with their children. This visit is the first time that StoryCorps, the largest oral history project of its kind, has partnered to collect the stories of cancer survivors on a single topic.
U.S. trial shows no early mortality benefit from annual prostate cancer screening
The prostate cancer screening tests that have become an annual ritual for many men don’t appear to reduce deaths from the disease, at least among those with a limited life-expectancy, according to early results of a major U.S. study involving 75,000 men.
Blocking protein may help ease painful nerve condition
Exposure to a chemotherapeutic drug makes the branches of a normal nerve cell degenerate (left).Scientists have identified the first gene that pulls the plug on ailing nerve cell branches from within the nerve cell, possibly helping to trigger the painful condition known as neuropathy. The condition is a side effect of some forms of chemotherapy and can also afflict patients with cancer, diabetes, kidney failure, viral infections, neurodegenerative disorders and other ailments.
Researchers Find Sustained Improvement in Health in Experience Corps Tutors Over 55
Tutors over 55 who help young students on a regular basis experience positive physical and mental health outcomes, according to studies released by researchers at Washington University in St. Louis and Johns Hopkins University School of Medicine. The tutors studied were members of Experience Corps, an award-winning organization that trains thousands of people over 55 to tutor children in urban public schools across the country. Researchers at Washington University’s Center for Social Development assessed the impact of the Experience Corps program on the lives of its members and found that, compared with adults of similar age, demographics and volunteer history, Experience Corps tutors reported improvements in mental health and physical functioning (including mobility, stamina and flexibility) and maintained overall health longer. Video Available
Well-known enzyme is unexpected contributor to brain growth
An enzyme researchers have studied for years because of its potential connections to cancer, diabetes, heart disease, hypertension and stroke appears to have yet another major role to play: helping create and maintain the brain. When scientists at the School of Medicine selectively disabled the enzyme AMP-activated protein kinase (AMPK) in mouse embryos, overall brain size was reduced by 50 percent, the cerebrum and cerebellum were shrunken, and the mice died within three weeks of birth.
Brain damage found in cognitively normal people with Alzheimer’s marker
Researchers at the School of Medicine have linked a potential indicator of Alzheimer’s disease to brain damage in humans with no signs of mental impairment. Although their cognitive and neurological assessments were normal, study participants with lower levels of a substance known as amyloid beta 42 (A-beta 42) in their cerebrospinal fluid (CSF) had reduced whole brain volumes, suggesting that Alzheimer’s changes might already be damaging their brains.
Older Stories